5042
H. Hagiwara et al. / Tetrahedron 57 -2001) 5039±5043
101.8, 126.4, 126.5, 128.3, 128.5, 128.6, 131.1, 136.4,
139.7, 164.1, 164.8 and 166.8; 7Found: C, 71.28, H, 5.87;
C21H20O3S requires: C, 71.56, H, 5.72%).
cm21 7CHCl3) 2951, 1709, 1643, 1564, 1466, 1264, 1040
and 1036; 1H-NMR 7200 MHz) d 7ppm) 2.78±2.89 7m, 2H),
2.95±3.06 7m, 2H), 3.60 7s, 3H), 3.87 7d, 1H, J 12.1 Hz),
4.09 7d, 1H, J 12.1Hz), 5.84 7s, 1H), 7.13±7.36 7m, 5H),
7.37±7.52 7m, 3H) and 7.57±7.69 7m, 2H); 13C-NMR
750MHz) 32.9, 36.1, 53.2, 56.5, 94.6, 94.7, 124.3, 126.5,
128.2, 128.5, 128.6, 131.0, 139.4, 144.2, 163.9, 166.0 and
168.6.
1.1.9. 6-Cyclohexyl-4-methoxy-3-phenylthiomethyl-2H-
pyran-2-one *10d). 86%; needles; m.p. 145±1468C; nmax
/
cm21 7CHCl3) 2938, 1697, 1564, 1464, 1127 and 1033;
1H-NMR 7200 MHz) d 7ppm) 1.18±1.53 7m, 5H), 1.65±
2.02 7m, 5H), 2.42 7m, 1H), 3.74 7s, 3H), 3.99 7s, 2H),
5.91 7s, 1H) and 7.12±7.48 7m, 5H); 13C-NMR 750MHz)
d 7ppm) 25.6, 25.8, 28.1, 30.5, 42.8, 56.3, 92.0, 101.5, 126.2,
128.5, 130.7, 136.7, 164.2, 167.2 and 170.4; 7Found: C,
68.79, H, 6.69, S, 9.78; C19H22O3S requires: C, 69.06, H,
6.71, S, 9.7%).
1.1.14. 6-Cyclohexyl-4-methoxy-3-phenylsul®nylmethyl-
2H-pyran-2-one *11d). 90%; blocks; m.p. 139±1418C;
n
max/cm21 7CHCl3) 2859, 1703, 1640, 1563, 1466, 1260,
1
1031 and 1024; H-NMR 7200 MHz) d 7ppm) 1.22±1.35
7m, 5H), 1.78±2.03 7m, 5H), 2.43 7m, 1H), 3.76 7s, 3H),
3.84 7d, 1H, J 12.2 Hz), 4.11 7d, 1H, J 12.2 Hz), 5.94 7s,
1H), 7.43±7.52 7m, 3H) and 7.62±7.71 7m, 5H); 13C-NMR
750 MHz) 25.6, 25.7, 30.4, 42.9, 53.5, 56.5, 92.0, 94.9,
124.3, 128.7, 130.9, 144.5, 164.1, 169.1 and 171.5.
1.1.10.
pyran-2-one *10e). 36%; needles; m.p. 93±948C; nmax
5,6-Benzo-4-methoxy-3-phenylthiomethyl-2H-
/
cm21 7CHCl3) 1712, 1625, 1622, 1456, 1354, 1273, 1099
1
and 1057; H-NMR 7200 MHz) d 7ppm) 4.02 7s, 3H), 4.18
7s, 2H), 7.17±7.407m, 5H), 7.45±7.65 7m, 3H) and 7.67±
7.72 7m, 1H); 13C-NMR 750MHz) d 7ppm) 29.6, 62.4,
112.7, 116.7, 117.0, 123.5, 124.1, 126.9, 128.9, 130.9,
132.0, 136.0, 152.8, 162.8 and 164.7; 7Found: C, 68.31,
H, 4.77, S, 10.58; C17H14O3S requires: C, 68.44, H, 4.73,
S, 10.75%).
1.1.15. 5,6-Benzo-4-methoxy-3-phenylsul®nylmethyl-2H-
pyran-2-one *11e). 58%; needles; m.p. 121±1238C; nmax
/
cm21 7CHCl3) 1713, 1626, 1613, 1572, 1354, 1101, 1063
and 1043; H-NMR 7200 MHz) d 7ppm) 4.02 7d, 1H, J
1
12.5 Hz), 4.23 7d, 1H, J 12.5 Hz), 4.23 7s, 3H), 7.28±7.42
7m, 2H), 7.50±7.65 7m, 4H) and 7.71±7.80 7m, 3H); 13C-
NMR 750 MHz) 55.4, 64.0, 106.1, 116.6, 117.0, 123.8,
123.9, 124.3, 129.2, 131.2, 132.5, 144.1, 152.9, 162.9 and
167.2; 7Found: C, 64.76, H, 4.68, S, 10.26; C17H14O4S
requires: C, 64.95, H, 4.49, S, 10.20%).
Representative procedure of oxidation is as follows:
1.1.11. 4-Methoxy-6-methyl-3-phenylsul®nylmethyl-2H-
pyran-2-one *11a). To a stirred solution of the sul®de 10a
71.11 g, 4.2 mmol) in CH2Cl2 730ml) was added MCPBA
780%, 913 mg, 5.3 mmol) at 08C. After being stirred for
20min, aqueous sodium hydrogen carbonate was added
and the reaction mixture was extracted with CH2Cl2 twice.
The combined organic layer was washed with water and
brine and evaporated to dryness. The residue was puri®ed
by column chromatography to afford 4-methoxy-6-methyl-
3-phenylsul®nylmethyl-2H-pyran-2-one 11a 71.13 g, 96%).
Representative procedure of hydroxymethylation is as
follows:
1.1.16.
3-Hydroxymethyl-4-methoxy-6-methyl-2H-
pyran-2-one *7a). To a stirred solution of the sulfoxide
11a 727.7 mg, 0.1 mmol) in CH2Cl2 7EtOH free, 4 ml) was
added tri¯uoroacetic anhydride 756 ml, 0.4 mmol) at 08C.
After being stirred for 30min at 0 8C, 1N aqueous NaOH
71 ml) and THF 76 ml) were added and stirring was con-
tinued for 1.5 h at room temperature. The reaction mixture
was extracted with ethyl acetate twice and the combined
organic layer was washed with aqueous ammonium
chloride, water and brine. Evaporation of the solvent
followed by MPLC puri®cation furnished 3-hydroxy-
methyl-4-methoxy-6-methyl-2H-pyran-2-one 7a 711.5 mg,
68%). In this experiment, use of a rubber septum and
balloon provided a complex mixture of undesired products.
96%; blocks; m.p. 128±1308C; nmax/cm21 7CHCl3) 3050,
1705, 1645, 1566, 1468, 1264, 1038 and 1022; H-NMR
1
7200 MHz) d 7ppm) 2.29 7s, 3H), 3.68 7d, 1H, J 12.2 Hz),
3.73 7s, 3H), 4.11 7d, 1H, J 12.2 Hz), 5.99 7s, 1H), 7.44±7.53
7m, 3H) and 7.61±7.71 7m, 2H); 13C-NMR 750MHz) d
7ppm) 20.4, 53.1, 56.5, 94.1, 94.7, 124.2, 128.6, 130.9,
144.2, 163.9 and 168.8; 7Found: C, 60.3, H, 5.12, S,
11.46; C14H14O4S requires: C, 60.42, H, 5.07, S, 11.52%).
1.1.12. 4-Methoxy-6-nonyl-3-phenylsul®nylmethyl-2H-
pyran-2-one *11b). 86%; needles; m.p. 85±868C; nmax
68%; blocks; m.p. 151±1538C; nmax/cm21 7CHCl3) 3472,
2951, 1694, 1645, 1568, 1389, 1260and 1022; 1H-NMR
7200 MHz) d 7ppm) 2.307s, 3H), 3.91 7s, 3H), 4.54 7s,
2H), and 6.08 7s, 1H); 13C-NMR 750MHz) d 7ppm) 20.4,
54.5, 56.4, 95.1, 103.6, 163.3, 165.3 and 166.8; 7Found: C,
56.36, H, 5.98; C8H10O4 requires: C, 56.47, H, 5.92%).
/
cm21 7CHCl3) 2930, 2857, 1703, 1642, 1564, 1466, 1267
and 1032; H-NMR 7200 MHz) d 7ppm) 0.89 7t, 3H, J
1
6.4 Hz), 1.22±1.38 7m, 12H), 1.60±1.74 7m, 2H), 2.51 7t,
2H, J 7.5 Hz), 3.74 7s, 3H), 3.86 7d, 1H, J 12.1 Hz), 4.11 7d,
1H, J 12.1 Hz), 5.96 7s, 1H), 7.44±7.52 7m, 3H) and 7.62±
7.71 7m, 2H); 13C-NMR 750MHz) d 7ppm) 14.0, 22.5, 26.8,
28.8, 29.1, 29.3, 31.7, 34.3, 53.3, 56.5, 93.9, 94.5, 124.2,
128.6, 130.9, 144.3, 164.0, 167.7 and 168.8; 7Found: C,
67.38, H, 7.80, S, 8.38; C22H30O4S requires: C, 67.66, H,
7.74, S, 8.21%).
1.1.17. 3-Hydroxymethyl-4-methoxy-6-nonyl-2H-pyran-
2-one *7b). 82%; needles; m.p. 67±688C; nmax/cm21
7CHCl3) 3504, 2930, 1692, 1640, 1566, 1402, 1264 and
1
1030; H-NMR 7200 MHz) d 7ppm) 0.88 7t, 3H, J 6.4 Hz),
1.20±1.42 7m, 12H), 1.52±1.76 7m, 2H), 2.51 7t, 2H, J
7.5 Hz), 2.93 7t, 1H, J 6.8 Hz), 3.91 7s, 3H), 4.54 7d, 2H, J
6.8 Hz) and 6.04 7s, 1H); 13C-NMR 750MHz) d 7ppm) 14.1,
22.6, 27.0, 29.0, 29.2, 29.4, 31.8, 34.4, 54.7, 56.5, 94.3,
1.1.13. 4-Methoxy-6-*2-phenylethyl)-3-phenylsul®nyl-
methyl-2H-pyran-2-one *11c). 93%; viscous oil; nmax
/